ReviewFrontiers in pharmacology2025
Digital interventions in medication adherence: a narrative review of current evidence and challenges.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Assessment Tools for Adherence to Prophylactic Haemophilia Treatment in Adult and Adolescent Patients: A Systematic Review.Haemophilia : the official journal of the World Federation of HemophiliaPooled it
- Digital and Biomarker-Based Monitoring for Schizophrenia-Treatment Adherence.Neuropsychopharmacology reports · 2026Review
- Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B.World journal of virology · 2026Article
- Healthcare professionals' perspectives on medication adherence-supporting tools: a cross‑sectional survey in Italy.European journal of clinical pharmacology · 2026Article
- Determinants of mobile health application utilization in Lebanon: a cross-sectional study of perceptions, barriers, and engagement.BMC public health · 2026Article
- Effectiveness of artificial intelligence mobile app-guided prevention and treatment protocols on cancer patients and their impact on healthcare workers' competence.BMC medical informatics and decision making · 2026Article
- Medication Adherence in Women with Early-Stage Breast Cancer and Active Parenting Responsibilities: The Mediating Role of Parenting Stress and Spiritual Well-Being.Medicina (Kaunas, Lithuania) · 2026Article
- Artificial Intelligence in Medication Adherence: A National Assessment of Knowledge, Attitudes, and Perceptions Among Chronic Disease Patients in Jordan.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-adherence to prescribed treatments remains a major challenge facing the healthcare system. Despite decades of research, interventions to improve adherence typically have not shown large or sustained effects on adherence and are rarely implemented. Digital technologies provide a potential platform to increase the reach and cost-effectiveness of adherence interventions, allowing them to be widely rolled out. Current evidence suggests that digital interventions can increase adherence, but results are mixed with many interventions failing to improve adherence. This is likely because whilst the included interventions all utilise digital platforms, they vary significantly in their design, content and delivery. Many interventions are not theory or evidence based, do not include patient or healthcare practitioner involvement or focus simply on providing reminders. Evidence suggests that well-designed interventions which are evidence-based, are personalised and maximise interactivity are more likely to be successful. These well-designed interventions hold promise for improving adherence at scale. This narrative review discusses the current challenges facing digital adherence interventions and describes barriers to implementation or adoption which need to be resolved. These include considering reach, accessibility, and acceptability, to avoid increasing existing health inequalities. It is also critical to consider the quality, safety and regulation of available apps and other digital tools, as well as investigating ways to enhance engagement and retention. Finally, some digital tools may require integration into existing systems or may necessitate training of relevant staff. Overall, digital interventions appear to be a promising tool for improving medication adherence, but further work is needed to optimise these tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.